Intra-Cellular Therapies
ITCI
Reported
Friday, February 21
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.12 | -0.16 | -0.04 | -33.33% |
| Revenue | 194M | 199M | 5.26M | 2.71% |
WhatIF - Earnings
EPS Missed Expectations by -$0.04
Intra-Cellular Therapies (ITCI:NASDAQ) has never missed EPS by this much before
There’s a first time for everything